Moderna, Merck say their cancer vaccine reduces metastases by 65% in PhII study of high-risk melanoma: #ASCO23 – Endpoints News June 5, 2023
Gilead, Arcus’ updated TIGIT data unlikely to resolve debates around space: #ASCO23 – Endpoints News June 3, 2023